XTLB - X.T.L. Biopharmaceuticals Ltd. - ADR
Previous close
2.72
0 0%
Share volume: 701
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.72
0.00
0.00%
Summary score
15%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.08%
Return on assets
-4.17%
Return on sales
0%
Return on invested capital
6640.15%
Total debt ratio
19.48%
Debt ratio change over timeo
-1.1%
Current Ratio
28.65%
Quick Ratio
0%
Cash Position Ratio
14.36%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.44%
Return on assets
-2.17%
Return on sales
0%
Return on invested capital
298.68%
Total debt ratio
2.35%
Debt ratio change over timeo
-1%
Current Ratio
42.04%
Quick Ratio
0%
Cash Position Ratio
20.24%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-15.65%
Return on assets
-2.42%
Return on sales
0%
Return on invested capital
-695.44%
Total debt ratio
2.41%
Debt ratio change over time
-1%
Current Ratio
39.54%
Quick Ratio
0%
Cash Position Ratio
23.21%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-144.7%
Return on assets
-90.34%
Return on sales
0%
Return on invested capital
-904.24%
Total debt ratio
-110.16%
Debt ratio change over time
-1.1%
Current Ratio
-75.84%
Quick Ratio
0%
Cash Position Ratio
-13.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XTLB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.08% | 5.89% | 9.6% | 6.01% |
| Return on assets | -4.17% | 3.81% | 3.52% | 5.45% |
| Return on sales | 0% | 33.24% | 43.6% | 33.16% |
| Return on invested capital | 6640.15% | 4.43% | 8.45% | 11.66% |
| Profitability | 25% | 52% | 66% | 60% |
| Total debt ratio | 19.48% | 99.62% | 70.37% | 29.84% |
| Debt ratio change over time | -1.1% | 15.49% | 5.02% | 1.76% |
| Dept financing | 5% | 50% | 26% | 10% |
| Current Ratio | 42.04% | 1.02% | 2.84% | 4.24% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.46% |
| Cash Position Ratio | 20.24% | 0.44% | 0.67% | 1.82% |
| Liquididy | 50% | 10% | 30% | 26% |
| Short-term ratios | XTLB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -0.44% | -10.21% | 18% | 5.65% |
| Return on assets | -2.17% | 3.12% | 3.99% | 4.39% |
| Return on sales | 0% | 21.95% | 42.62% | 29.42% |
| Return on invested capital | 298.68% | 3.21% | 12.03% | 12.26% |
| Profitability | 25% | 31% | 74% | 51% |
| Total debt ratio | 2.35% | 114.21% | 81.93% | 25.62% |
| Debt ratio change over time | -1% | 17.86% | 5.8% | 2.14% |
| Dept financing | 1% | 50% | 26% | 9% |
| Current Ratio | 42.04% | 1.02% | 2.84% | 4.24% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.46% |
| Cash Position Ratio | 20.24% | 0.44% | 0.67% | 1.82% |
| Liquididy | 50% | 8% | 21% | 30% |